Shares of Bruker Biosciences gained 13.4 percent for the trading week ended Tuesday, reversing a 7-percent decline the week before. The firm led the seven companies in the BCW Index that gained ground for the tracking period. Stratagene led decliners in the Index with a drop of 9.3 percent. Its shares reached a 52-week low of $5.51 on Tuesday before closing at $5.67.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Congress approved a bill Friday that would increase the US National Institutes of Health's funding by $2 billion for fiscal year 2019.

Sarah Lawrence College's Laura Hercher warns in a New York Times op-ed that more people are going to need help figuring out what their consumer genetic testing results mean.

UK's Labour Party calls for a ban on non-invasive prenatal testing for determining sex, BBC News reports.

In PLOS this week: intra-tumor heterogeneity patterns, genomic analysis of Thoroughbred horse origins, and more.